Glynis L Kolling

Title: Innovations by Glynis L Kolling

Introduction

Glynis L Kolling is an accomplished inventor based in Scottsville, Virginia. She has made significant contributions to the field of biotherapeutics, particularly in the targeted delivery of therapeutic agents. Her innovative work has the potential to address various gastrointestinal disorders.

Latest Patents

Glynis L Kolling holds one patent titled "Methods and compositions for targeted delivery of biotherapeutics." This patent describes compositions that include bile-sensitive bacteria modified to release biotherapeutic agents following bile exposure. The biotherapeutic agents released by these bacteria include AQ and AQR rich peptides. The methods outlined in her patent involve administering a modified bacterium to a subject, which promotes a desired therapeutic response. This invention is particularly useful in treating or preventing gastrointestinal disorders, including infections and antibiotic-associated diarrhea.

Career Highlights

Throughout her career, Glynis has worked with prestigious institutions such as North Carolina State University and the University of Virginia. Her research has focused on the intersection of microbiology and therapeutic delivery systems, showcasing her expertise in the field.

Collaborations

Glynis has collaborated with notable colleagues, including Todd Robert Klaenhammer and Richard Littleton Guerrant. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Glynis L Kolling's work in biotherapeutics exemplifies the impact of innovative research on healthcare. Her contributions are paving the way for new treatments for gastrointestinal disorders, highlighting the importance of targeted therapeutic delivery systems.